245 related articles for article (PubMed ID: 30774578)
1. Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis.
Tian Y; Li H; Gao Y; Liu C; Qiu T; Wu H; Cao M; Zhang Y; Ding H; Chen J; Cai H
Clin Proteomics; 2019; 16():6. PubMed ID: 30774578
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Åhrman E; Hallgren O; Malmström L; Hedström U; Malmström A; Bjermer L; Zhou XH; Westergren-Thorsson G; Malmström J
J Proteomics; 2018 Oct; 189():23-33. PubMed ID: 29501846
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.
Velázquez-Enríquez JM; Ramírez-Hernández AA; Navarro LMS; Reyes-Avendaño I; González-García K; Jiménez-Martínez C; Castro-Sánchez L; Sánchez-Chino XM; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563422
[TBL] [Abstract][Full Text] [Related]
4. iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis.
Niu R; Liu Y; Zhang Y; Zhang Y; Wang H; Wang Y; Wang W; Li X
PLoS One; 2017; 12(1):e0170741. PubMed ID: 28122020
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Analysis Reveals Key Proteins in Extracellular Vesicles Cargo Associated with Idiopathic Pulmonary Fibrosis In Vitro.
Velázquez-Enríquez JM; Santos-Álvarez JC; Ramírez-Hernández AA; Reyes-Jiménez E; López-Martínez A; Pina-Canseco S; Aguilar-Ruiz SR; Romero-Tlalolini MLÁ; Castro-Sánchez L; Arellanes-Robledo J; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440261
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis.
Samarelli AV; Tonelli R; Raineri G; Bruzzi G; Andrisani D; Gozzi F; Marchioni A; Costantini M; Fabbiani L; Genovese F; Pinetti D; Manicardi L; Castaniere I; Masciale V; Aramini B; Tabbì L; Rizzato S; Bettelli S; Manfredini S; Dominici M; Clini E; Cerri S
Front Oncol; 2023; 13():1275346. PubMed ID: 38322285
[TBL] [Abstract][Full Text] [Related]
7. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
[TBL] [Abstract][Full Text] [Related]
8. Systems Analysis of Transcriptomic and Proteomic Profiles Identifies Novel Regulation of Fibrotic Programs by miRNAs in Pulmonary Fibrosis Fibroblasts.
Mullenbrock S; Liu F; Szak S; Hronowski X; Gao B; Juhasz P; Sun C; Liu M; McLaughlin H; Xiao Q; Feghali-Bostwick C; Zheng TS
Genes (Basel); 2018 Nov; 9(12):. PubMed ID: 30501089
[TBL] [Abstract][Full Text] [Related]
9. Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis.
Elowsson Rendin L; Löfdahl A; Åhrman E; Müller C; Notermans T; Michaliková B; Rosmark O; Zhou XH; Dellgren G; Silverborn M; Bjermer L; Malmström A; Larsson-Callerfelt AK; Isaksson H; Malmström J; Westergren-Thorsson G
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426504
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an
Merl-Pham J; Basak T; Knüppel L; Ramanujam D; Athanason M; Behr J; Engelhardt S; Eickelberg O; Hauck SM; Vanacore R; Staab-Weijnitz CA
Matrix Biol Plus; 2019 Feb; 1():100005. PubMed ID: 33543004
[TBL] [Abstract][Full Text] [Related]
11. Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosis.
Moodley YP; Corte TJ; Oliver BG; Glaspole IN; Livk A; Ito J; Peters K; Lipscombe R; Casey T; Tan DBA
Respirology; 2019 Nov; 24(11):1111-1114. PubMed ID: 31393655
[TBL] [Abstract][Full Text] [Related]
12. A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.
Landi C; Bargagli E; Carleo A; Bianchi L; Gagliardi A; Prasse A; Perari MG; Refini RM; Bini L; Rottoli P
Proteomics Clin Appl; 2014 Dec; 8(11-12):932-50. PubMed ID: 25169739
[TBL] [Abstract][Full Text] [Related]
13. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
14. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
[TBL] [Abstract][Full Text] [Related]
17. Translational control of the fibroblast-extracellular matrix association: An application to pulmonary fibrosis.
Nho RS; Polunovsky V
Translation (Austin); 2013; 1(1):e23934. PubMed ID: 26824013
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis.
Kang YP; Lee SB; Lee JM; Kim HM; Hong JY; Lee WJ; Choi CW; Shin HK; Kim DJ; Koh ES; Park CS; Kwon SW; Park SW
J Proteome Res; 2016 May; 15(5):1717-24. PubMed ID: 27052453
[TBL] [Abstract][Full Text] [Related]
19. Fibrotic extracellular matrix activates a profibrotic positive feedback loop.
Parker MW; Rossi D; Peterson M; Smith K; Sikström K; White ES; Connett JE; Henke CA; Larsson O; Bitterman PB
J Clin Invest; 2014 Apr; 124(4):1622-35. PubMed ID: 24590289
[TBL] [Abstract][Full Text] [Related]
20. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
